Palvella Therapeutics (PVLA) Invested Capital (2013 - 2014)
Palvella Therapeutics' (PVLA) quarterly Invested Capital came in at $1.3 million in Q4 2014, up 515.33% year-on-year from $206490.0 in Q4 2013, and up 36474.7% on a QoQ basis from $3474.0 in Q3 2014.
Palvella Therapeutics (PVLA) Invested Capital (2013 - 2014) Analysis & Trends
Palvella Therapeutics (PVLA) has 2 years of Invested Capital data on file, last reported at $1.3 million in Q4 2014.
- On a quarterly basis, Invested Capital rose 515.33% year-over-year to $1.3 million in Q4 2014; TTM through Sep 2015 was $1.3 million, a 503.79% increase from a year earlier, with the FY2014 full-year figure at $1.3 million, up 515.33% from the prior year.
- Invested Capital for Q4 2014 stood at $1.3 million, up from $3474.0 in the prior quarter.
- Over the last five years, Invested Capital for PVLA reached as high as $1.3 million in Q4 2014 and fell as low as $474.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 1.27 Mn |
| Sep 30, 2014 | 3,474.00 |
| Jun 30, 2014 | 474.00 |
| Dec 31, 2013 | 206,490.00 |